Search

Your search keyword '"Saito, Yoshiro"' showing total 1,582 results

Search Constraints

Start Over You searched for: Author "Saito, Yoshiro" Remove constraint Author: "Saito, Yoshiro"
1,582 results on '"Saito, Yoshiro"'

Search Results

1. Ferroptosis in health and disease.

6. Identification of kynurenine and quinolinic acid as promising serum biomarkers for drug-induced interstitial lung diseases

16. PRDX6 dictates ferroptosis sensitivity by directing cellular selenium mobilization

19. Identification and characterization of lysophosphatidylcholine 14:0 as a biomarker for drug-induced lung disease

20. Stratifin as a novel diagnostic biomarker in serum for diffuse alveolar damage

24. Association of HLA-A∗11:01, HLA-B∗39:01, and HLA-B∗56:03 with salazosulfapyridine-induced cutaneous adverse drug reactions

38. Pharmacokinetic Models Scaled Up from Humanized Liver Mouse Data Can Account for Drug Monitoring Results of Atomoxetine and Its 4-Hydroxylated andN-Demethylated Metabolites in Pediatric Patients Genotyped for CytochromeP450 2D6

40. Relationship between the lipidome profile and disease activity in patients with rheumatoid arthritis

41. DJ-1 as a Biomarker of Parkinson’s Disease

43. Differential Effects of HLA-B∗15:11 and HLA-A∗31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions

44. 2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs (Part 1A – Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine)

45. Development and validation of qPCR methods for nucleic acid biomarkers as a drug development tool: points to consider

46. 2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles Part 2 – Recommendations on Biomarkers/CDx, Flow Cytometry, Ligand-Binding Assays Development & Validation; Emerging Technologies; Critical Reagents Deep Characterization

47. Impact of microsampling on toxicological evaluation in rodent safety studies

Catalog

Books, media, physical & digital resources